DAS
CSTL icon

Diversify Advisory Services’s Castle Biosciences CSTL Stock Holding History

Diversify Advisory Services’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Buy
+15,932
New +$355K 0.01% 959
2024
Q2 		– Sell
-12,498
Closed -$278K – 658
2024
Q1 		$278K Buy
+12,498
New +$272K 0.02% 547

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diversify Advisory Services's CSTL Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Castle Biosciences (CSTL) in Q2 2026: 15,932 shares worth $389K. The stake represents 0.01% of the portfolio and ranks #959 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in CSTL as recently as Q1 2024.

Diversify Advisory Services first reported a position in CSTL in Q1 2024 and has held it in 2 quarters since. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Diversify Advisory Services held 15,932 shares of Castle Biosciences worth $389K as of Q2 2026.
  • Castle Biosciences was a new Diversify Advisory Services position in Q2 2026.
  • Castle Biosciences made up 0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #959 holding.
  • Diversify Advisory Services first reported a position in Castle Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.